IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy.
about
Post-treatment imaging changes in primary brain tumors.Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?Is there pseudoprogression in secondary glioblastomas?A preliminary quantitative proteomic analysis of glioblastoma pseudoprogressionStratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation.Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics studyEarly Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation.Pseudoprogression as an adverse event of glioblastoma therapy.Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and TemozolomiPseudoprogression after glioma therapy: an update.Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.
P2860
Q30835236-E53E63CF-B159-456C-A40E-6BF8EBBF7365Q30937034-23222DE0-0676-48C5-BAFA-47BB2A190C90Q35146128-40BCF23A-EC0F-4B2D-970D-D284E9134008Q35368468-20EB2F0F-75FB-40D2-9F32-A4DA99361A3FQ37321862-51C3576D-6CE6-4EEB-90BB-94680737FB28Q39598112-217A8868-2342-4DC7-A231-4D06DD7B78E1Q41845711-D0D22B3E-02BD-4D1F-BEE9-30C0F7623588Q47164037-6F5D5FD0-4F4A-4341-8B55-F001F1A3F53FQ47406548-AF8DBC6B-8230-449C-9DCB-5B0858B1BF18Q48130815-0F8B3D19-7406-44F9-BB94-BBD4C07E2D31Q55114505-F4E48B15-24AF-4233-AA09-B40FD8EA40F5
P2860
IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
IDH1 mutation as a potential n ...... temozolomide and radiotherapy.
@en
IDH1 mutation as a potential n ...... temozolomide and radiotherapy.
@nl
type
label
IDH1 mutation as a potential n ...... temozolomide and radiotherapy.
@en
IDH1 mutation as a potential n ...... temozolomide and radiotherapy.
@nl
prefLabel
IDH1 mutation as a potential n ...... temozolomide and radiotherapy.
@en
IDH1 mutation as a potential n ...... temozolomide and radiotherapy.
@nl
P2093
P2860
P1476
IDH1 mutation as a potential n ...... temozolomide and radiotherapy.
@en
P2093
Hiroaki Motegi
Hiroyuki Kobayashi
Junichi Murata
Kiyohiro Houkin
Mishie Tanino
Shigeru Yamaguchi
Shunsuke Terasaka
Yuuta Kamoshima
P2860
P2888
P356
10.1007/S10014-012-0109-X
P577
2012-07-03T00:00:00Z
P6179
1012468803